Comparison of Two Methods of Adjusting the Mechanical In-Exsuflation in Neuromuscular Adult Patients
EXSUFLOW
2 other identifiers
interventional
29
1 country
1
Brief Summary
In the context of neuromuscular diseases, the weakness of the respiratory muscles makes difficult to manage periods of congestion due to a less effective cough. It exposes the patient to bronchial superinfections that may require hospitalization. The use of cough assistance is therefore essential in order to avoid acute situations such as bronchial superinfections. Mechanical Insuflation-Exsufflation (MI / E) is an instrumental technique commonly used by therapists in a hospital or at the patient's home in order to facilitate the airway mucus clearance. The choice of the pressure settings of the IM / E is a decisive point because it conditions the effectiveness of the generated cough. It'is important to take into account the presence of any collapse in the use of IM / E in order to ensure the most effective cough given by the patient. Actually, except the common impression of the physiotherapist and the patient, there is no "simple" way for detecting and objectifying the threshold of collapse in the upper airways. The aim of this study is to compare two modalities for the regulation of the level of the MI-E exsufflation, taking into account the presence of a collapse: a subjective "S" adjustment based on the clinical judgment of the therapist and the patient and an objective "O" adjustment based on the flow-volume curve generated during the cough.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2017
CompletedFirst Posted
Study publicly available on registry
November 28, 2017
CompletedStudy Start
First participant enrolled
March 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2024
CompletedJune 11, 2024
June 1, 2024
5.8 years
November 22, 2017
June 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Area Under Curve (AUC) Flow Volume
The primary endpoint is the Area Under Curve (AUC) Flow Volume during the cough expiratory phase. To compare the cough effectiveness obtained according to the current modalities of the MI / E exsuflation pressure setting to that resulting from an adjustment based on the analysis of the flow-volume curve.
At baseline
Secondary Outcomes (5)
Peak Cough Flow (PCF)
At baseline
Evaluate the association between the peak cough flow (PCF) generated and the subjective criteria
At baseline
Subjective Therapist Cough Effectiveness
At baseline
Subjective Patient Cough Effectiveness
At baseline
Respiratory comfort
At baseline
Study Arms (2)
Objective adjustment of the MI/E exsuflation pressure
EXPERIMENTALObjective adjustment of the MI/E exsuflation pressure based on the flow-volume curve generated during the cough.
Subjective adjustment of the MI/E exsuflation pressure
ACTIVE COMPARATORSubjective adjustment of the MI/E exsuflation pressure based on the clinical judgment of the therapist and the patient.
Interventions
The exsufflation pressures will be progressively increased starting from -20 cmH2O with 10 cmH2O increments up. 3 coughing operations will be realised for each level, until obtention of 10% of AUC decrease or a PCF collapse of at least 10% over the last 2 levels and without exceeding -70 cmH2O. The selected landing will be the one allowing the largest PCF without presence of collapse. An intermediate bearing between 2 bearings may be tested in order to approach an optimum adjustment threshold less than 5 cmH2O.
The exsufflation pressures will be gradually increased from -20 cmH2O, with 10 cmH2O increments up to a maximum of -70 cmH2O. The selected level will be the one selected both by the patient and the "clinician" therapist and considered as making it possible to obtain the most effective cough according to the return of the patient.
Eligibility Criteria
You may qualify if:
- Aged ≥18 years
- Neuromuscular pathology
- Coughing aid information: DEPT \<180 l / min
- In stable condition and without bulk
- Good understanding and cognition to follow the instructions and to inform the EVA
- Affiliated to a Sickness Insurance Plan or entitled
- Signed of informed consent
You may not qualify if:
- Pregnant woman
- Person under guardianship
- Inability to cooperate and / or communicate
- Acute decompensated organ
- Patient with following contraindications to mechanical in-exsufflation (MI-E) devices:
- pneumothorax
- pneumomediastinum
- pulmonary emphysema
- hemoptysis
- pleurisy
- nausea
- obstructive pulmonary disease or asthma
- recent lobectomy of the lung
- intracranial pressure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Physiology and Functional Explorations, Raymond Poincaré Hospital
Garches, Hauts-de-Seine, 92380, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Frédéric LOFASO, MD, PhD
Department of Physiology and Functional Explorations, Raymond Poincaré Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2017
First Posted
November 28, 2017
Study Start
March 7, 2019
Primary Completion
December 23, 2024
Study Completion
December 24, 2024
Last Updated
June 11, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share